(Post-pandemic Era)-Global The Equine Pharmaceuticals and Supplements Market Segment Research Report 2023

Report ID: 874912 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Equine Pharmaceuticals and Supplements Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Equine Pharmaceuticals and Supplements Market by Value
      2.2.1 Global The Equine Pharmaceuticals and Supplements Revenue by Type
      2.2.2 Global The Equine Pharmaceuticals and Supplements Market by Value (%)
    2.3 Global The Equine Pharmaceuticals and Supplements Market by Production
      2.3.1 Global The Equine Pharmaceuticals and Supplements Production by Type
      2.3.2 Global The Equine Pharmaceuticals and Supplements Market by Production (%)

3. The Major Driver of The Equine Pharmaceuticals and Supplements Industry
    3.1 Historical & Forecast Global The Equine Pharmaceuticals and Supplements Demand
    3.2 Largest Application for The Equine Pharmaceuticals and Supplements (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Equine Pharmaceuticals and Supplements Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Equine Pharmaceuticals and Supplements Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Equine Pharmaceuticals and Supplements Average Price Trend
    12.1 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in US (2017-2021)
    12.2 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in Europe (2017-2021)
    12.3 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in China (2017-2021)
    12.4 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in Japan (2017-2021)
    12.5 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in India (2017-2021)
    12.6 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in Korea (2017-2021)
    12.7 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Equine Pharmaceuticals and Supplements Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Equine Pharmaceuticals and Supplements

14. The Equine Pharmaceuticals and Supplements Competitive Landscape
     14.1 Boehringer Ingelheim
        14.1.1 Boehringer Ingelheim Company Profiles
        14.1.2 Boehringer Ingelheim Product Introduction
        14.1.3 Boehringer Ingelheim The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Virbac
        14.2.1 Virbac Company Profiles
        14.2.2 Virbac Product Introduction
        14.2.3 Virbac The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Bayer Animal Health
        14.3.1 Bayer Animal Health Company Profiles
        14.3.2 Bayer Animal Health Product Introduction
        14.3.3 Bayer Animal Health The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Merck Animal Health
        14.4.1 Merck Animal Health Company Profiles
        14.4.2 Merck Animal Health Product Introduction
        14.4.3 Merck Animal Health The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 CEVA
        14.5.1 CEVA Company Profiles
        14.5.2 CEVA Product Introduction
        14.5.3 CEVA The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Zoetis
        14.6.1 Zoetis Company Profiles
        14.6.2 Zoetis Product Introduction
        14.6.3 Zoetis The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Kyoritsu Seiyaku
        14.7.1 Kyoritsu Seiyaku Company Profiles
        14.7.2 Kyoritsu Seiyaku Product Introduction
        14.7.3 Kyoritsu Seiyaku The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Dechra Veterinary Products
        14.8.1 Dechra Veterinary Products Company Profiles
        14.8.2 Dechra Veterinary Products Product Introduction
        14.8.3 Dechra Veterinary Products The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 Elanco Animal Health
        14.9.1 Elanco Animal Health Company Profiles
        14.9.2 Elanco Animal Health Product Introduction
        14.9.3 Elanco Animal Health The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Norbrook Equine
        14.10.1 Norbrook Equine Company Profiles
        14.10.2 Norbrook Equine Product Introduction
        14.10.3 Norbrook Equine The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 Vetoquinol
     14.12 Ouro Fino Saude
     14.13 Protexin Healthcare
     14.14 Audevard
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Equine Pharmaceuticals and Supplements Industry (Volume)
    Figure 2. The Equine Pharmaceuticals and Supplements Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Equine Pharmaceuticals and Supplements Revenue in 2021
    Figure 5. US The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Equine Pharmaceuticals and Supplements Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Equine Pharmaceuticals and Supplements Production, by Type (K Unit) (2017-2027)
    Table 5. The Equine Pharmaceuticals and Supplements Demand (K Unit) by Application (2017-2027)
    Table 6. The Equine Pharmaceuticals and Supplements Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Equine Pharmaceuticals and Supplements Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Equine Pharmaceuticals and Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Equine Pharmaceuticals and Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Equine Pharmaceuticals and Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Equine Pharmaceuticals and Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Equine Pharmaceuticals and Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Equine Pharmaceuticals and Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Equine Pharmaceuticals and Supplements Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Equine Pharmaceuticals and Supplements in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Equine Pharmaceuticals and Supplements in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Equine Pharmaceuticals and Supplements in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Equine Pharmaceuticals and Supplements in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Equine Pharmaceuticals and Supplements in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Equine Pharmaceuticals and Supplements in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Equine Pharmaceuticals and Supplements in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Boehringer Ingelheim Profiles
    Table 61. Boehringer Ingelheim The Equine Pharmaceuticals and Supplements Product Introduction
    Table 62. Boehringer Ingelheim The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Boehringer Ingelheim Strategic initiatives
    Table 64. Virbac Profiles
    Table 65. Virbac The Equine Pharmaceuticals and Supplements Product Introduction
    Table 66. Virbac The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Virbac Strategic initiatives
    Table 68. Bayer Animal Health Profiles
    Table 69. Bayer Animal Health The Equine Pharmaceuticals and Supplements Product Introduction
    Table 70. Bayer Animal Health The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Bayer Animal Health Strategic initiatives
    Table 72. Merck Animal Health Profiles
    Table 73. Merck Animal Health The Equine Pharmaceuticals and Supplements Product Introduction
    Table 74. Merck Animal Health The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Merck Animal Health Strategic initiatives
    Table 76. CEVA Profiles
    Table 77. CEVA The Equine Pharmaceuticals and Supplements Product Introduction
    Table 78. CEVA The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. CEVA Strategic initiatives
    Table 80. Zoetis Profiles
    Table 81. Zoetis The Equine Pharmaceuticals and Supplements Product Introduction
    Table 82. Zoetis The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Zoetis Strategic initiatives
    Table 84. Kyoritsu Seiyaku Profiles
    Table 85. Kyoritsu Seiyaku The Equine Pharmaceuticals and Supplements Product Introduction
    Table 86. Kyoritsu Seiyaku The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Kyoritsu Seiyaku Strategic initiatives
    Table 88. Dechra Veterinary Products Profiles
    Table 89. Dechra Veterinary Products The Equine Pharmaceuticals and Supplements Product Introduction
    Table 90. Dechra Veterinary Products The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Dechra Veterinary Products Strategic initiatives
    Table 92. Elanco Animal Health Profiles
    Table 93. Elanco Animal Health The Equine Pharmaceuticals and Supplements Product Introduction
    Table 94. Elanco Animal Health The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. Elanco Animal Health Strategic initiatives
    Table 97. Norbrook Equine Profiles
    Table 98. Norbrook Equine The Equine Pharmaceuticals and Supplements Product Introduction
    Table 99. Norbrook Equine The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. Norbrook Equine Strategic initiatives
    Table 101. Vetoquinol Profiles
    Table 102. Vetoquinol The Equine Pharmaceuticals and Supplements Product Introduction
    Table 103. Vetoquinol The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 104. Vetoquinol Strategic initiatives
    Table 105. Ouro Fino Saude Profiles
    Table 106. Ouro Fino Saude The Equine Pharmaceuticals and Supplements Product Introduction
    Table 107. Ouro Fino Saude The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 108. Ouro Fino Saude Strategic initiatives
    Table 109. Protexin Healthcare Profiles
    Table 110. Protexin Healthcare The Equine Pharmaceuticals and Supplements Product Introduction
    Table 111. Protexin Healthcare The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 112. Protexin Healthcare Strategic initiatives
    Table 113. Audevard Profiles
    Table 114. Audevard The Equine Pharmaceuticals and Supplements Product Introduction
    Table 115. Audevard The Equine Pharmaceuticals and Supplements Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Equine Pharmaceuticals and Supplements Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Equine Pharmaceuticals and Supplements Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Equine Pharmaceuticals and Supplements Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports